Skip to main content

ERRATUM article

Front. Microbiol., 02 April 2024
Sec. Virology

Erratum: Establishment and application of a rapid assay for GII.4/GII.17 NoV detection based on the combination of CRISPR/Cas13a and isothermal amplification

  • Frontiers Media SA, Lausanne, Switzerland

An Erratum on
Establishment and application of a rapid assay for GII.4/GII.17 NoV detection based on the combination of CRISPR/Cas13a and isothermal amplification

by Li, J.-H., Jing, D., Wang, Y., Xu, J., Yu, J., Du, H., et al. (2024). Front. Microbiol. 15:1334387. doi: 10.3389/fmicb.2024.1334387

Due to a production error, the Funding statement was erroneously not included in the final article. The Funding statement is as follows:

Funding

The study was supported by the Key-Area Research and Development Program of Guangdong Province (2022B1111020002), the National Natural Science Foundation of China (grant numbers 31771007 and 81773975), and the Natural Science Foundation of Guangdong Province, China (grant number 2019A1515010951).

The publisher apologizes for this mistake.

The original article has been updated.

Keywords: norovirus, genotype GII.4/GII.17, CRISPR/Cas13a, RAA, detection

Citation: Frontiers Production Office (2024) Erratum: Establishment and application of a rapid assay for GII.4/GII.17 NoV detection based on the combination of CRISPR/Cas13a and isothermal amplification. Front. Microbiol. 15:1405235. doi: 10.3389/fmicb.2024.1405235

Received: 22 March 2024; Accepted: 22 March 2024;
Published: 02 April 2024.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2024 Frontiers Production Office. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Frontiers Production Office, cHJvZHVjdGlvbi5vZmZpY2UmI3gwMDA0MDtmcm9udGllcnNpbi5vcmc=

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.